NASDAQ:PDLI - PDL BioPharma SEC Filings & 10K Form

$2.29
+0.05 (+2.23 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$2.21
Now: $2.29
$2.29
50-Day Range
$2.21
MA: $2.54
$2.99
52-Week Range
$2.15
Now: $2.29
$3.89
Volume1.91 million shs
Average Volume1.37 million shs
Market Capitalization$261.52 million
P/E Ratio6.19
Dividend YieldN/A
Beta0.69

SEC Filings

PDL BioPharma (NASDAQ:PDLI) SEC Filings

DateFilerForm TypeView
09/12/2019
8:49 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
8:57 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:42 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
3:32 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
4:18 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D/A
08/07/2019
3:22 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
4:02 PM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
11:16 PM
PDL BioPharma (Filer)
Form EFFECT
06/25/2019
4:24 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
8:44 PM
PDL BioPharma (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:41 PM
Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:40 PM
PDL BioPharma (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:39 PM
PDL BioPharma (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:38 PM
GRYSKA DAVID W (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:37 PM
O'Farrell Elizabeth G. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:36 PM
PDL BioPharma (Issuer)
Sandman Paul W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:34 PM
Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
8:32 PM
Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
8:06 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
5:16 PM
Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:02 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:07 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:03 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
5:10 AM
PDL BioPharma (Filer)
Form DEFA14A
04/30/2019
4:14 PM
PDL BioPharma (Filer)
Form DEFA14A
04/30/2019
4:08 PM
PDL BioPharma (Filer)
Form DEF 14A
04/18/2019
2:33 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D
04/18/2019
2:29 PM
Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2019
4:18 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
4:17 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4/A
04/16/2019
4:16 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
4:15 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
3:10 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
4:29 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
3:13 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
3:33 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
4:12 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:12 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:11 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:10 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
6:58 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
7:56 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
9:55 AM
PDL BioPharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/13/2019
9:09 AM
PDL BioPharma (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/08/2019
7:37 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
PDL BioPharma (Subject)
Form SC 13G/A
02/06/2019
2:05 PM
BlackRock Inc. (Filed by)
PDL BioPharma (Subject)
Form SC 13G/A
01/09/2019
9:26 AM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
9:26 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
5:30 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:30 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:29 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:28 PM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
7:21 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
8:18 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:03 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:08 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
7:37 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
8:24 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
3:42 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2018
3:41 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2018
3:40 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2018
3:40 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2018
8:12 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:31 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
3:11 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2018
3:10 PM
O'Farrell Elizabeth G. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:10 PM
O'Farrell Elizabeth G. (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2018
8:05 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
3:21 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
3:31 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:31 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:30 PM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:30 PM
Lindell Jody S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:29 PM
Edick Paul R (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:29 PM
PDL BioPharma (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:28 PM
GRYSKA DAVID W (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:28 PM
PDL BioPharma (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:28 PM
PDL BioPharma (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:27 PM
PDL BioPharma (Issuer)
Sandman Paul W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:12 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2018
3:12 PM
PDL BioPharma (Issuer)
Yanai Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2018
8:03 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
8:07 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
3:50 PM
PDL BioPharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/08/2018
12:00 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2018
8:01 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2018
8:06 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:09 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:03 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2018
3:43 PM
PDL BioPharma (Filer)
Form DEF 14A
04/16/2018
6:07 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2018
3:05 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2018
3:03 PM
PDL BioPharma (Subject)
Form PREC14A
03/16/2018
5:26 AM
PDL BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2018
8:35 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
3:02 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2018
5:06 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2018
7:07 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
8:32 AM
PDL BioPharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/14/2018
8:12 AM
PDL BioPharma (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel